您的位置: 首页 > 农业专利 > 详情页

INTRANASAL NANOCOMPOSITE OF DOLUTEGRAVIR FOR THE CNS DELIVERY.
专利权人:
发明人:
Ms Aarti V Belgamwar,Dr Shagufta A Khan,Dr Pramod G Yeole
申请号:
IN201721004980
公开号:
IN201721004980A
申请日:
2017.02.12
申请国别(地区):
IN
年份:
2017
代理人:
摘要:
Incapability of antiretrovirals (ARV) in complete eradication of HIV from latent reservoir is the biggest issue in the treatment of neuro-AIDS. Considering this, the present study is focused to enhance the CNS uptake of dolutegravir sodium (DTG) by designing intranasal DTG-nanoparticles (DTG-NPs). Spherical shaped stable DTG-NPs with low particle size and high drug loading were prepared. Sustained release from the nanoparticles and enhanced permeation through the nasal mucosa of drug could be achieved without adverse effect on it. The present discloser enhance CNS delivery of DTG using DTG-NPs and high drug targeting index to the brain makes a promising gateway in Neuro-AIDS.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充